605
Views
19
CrossRef citations to date
0
Altmetric
Drug Evaluations

Review on the clinical use of eribulin mesylate for the treatment of breast cancer

, &
Pages 589-600 | Received 27 Apr 2015, Accepted 20 Jan 2016, Published online: 17 Feb 2016

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.